Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

Writer Nick Harding has a blood test at a GFCT prostate cancer screening event at the Nelson Club in Warwick - Andrew Fox A few things are guaranteed to get men off the sofa and out the house.

Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...

Researchers have identified 17 unique genetic markers that are overexpressed by high-grade prostate cancers, which can be screened for accurately using a urine test. Experts say the test can help ...

A new at-home saliva test for prostate cancer could outperform current testing methods, a new study suggests. Researchers have developed a simple spit test, that can be performed at home and does not ...

Prostate health remains a crucial topic that many men avoid discussing, even with close family members. Early screenings can make a significant difference in detecting issues before they become severe ...

As men age, maintaining optimal prostate health becomes increasingly crucial. The prostate plays a vital role in urinary function and sexual health, and any issues can significantly impact quality of ...

Health Checkups for Men After Turning 40 Reaching the age of 40 is often seen as a significant milestone in life, marking the ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

The Decipher Prostate Metastatic test is now available for metastatic prostate cancer, covered by Medicare for all risk levels. It helps clinicians determine which patients may benefit from treatment, ...

To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...